 | • レポートコード：GIR-105X19871 • 出版社/出版日： / 2021年5月 • レポート形態：英文、PDF、102ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：Medical Devices & Consumables |
| Single User | ￥522,000 (USD3,480) | ▷ お問い合わせ |
| Multi User | ￥783,000 (USD5,220) | ▷ お問い合わせ |
| Corporate User | ￥1,044,000 (USD6,960) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料では、皮下ドラッグデリバリーデバイスのグローバル市場について調査・分析し、2021年から2026年までの市場予測をまとめております。皮下ドラッグデリバリーデバイスの種類別市場規模（プレフィルド注射剤、フィルド注射剤）、用途別市場規模（病院、クリニック、その他）、地域別市場規模（北米、アメリカ、ヨーロッパ、アジア、中国、日本、東南アジア、南米、中東、アフリカなど）、市場動向、企業別販売量と市場シェア、販売チャネルなどの情報を掲載しています。 ・皮下ドラッグデリバリーデバイスの市場概要 ・企業情報（企業概要、製品概要、販売量、価格、売上）：BD、Insulet Corporation、Enable Injections、West Pharmaceutical Services, Inc、Ypsomed AG、Elcam Medical、Amgen、Wilhelm Haselmeier ・企業別市場シェア ・地域別市場分析2016年-2026年 ・種類別分析2016年-2026年：プレフィルド注射剤、フィルド注射剤 ・用途別分析2016年-2026年：病院、クリニック、その他 ・皮下ドラッグデリバリーデバイスの北米市場規模2016年-2026年：アメリカ、カナダ、メキシコ ・皮下ドラッグデリバリーデバイスのヨーロッパ市場規模2016年-2026年：ドイツ、イギリス、フランス、ロシア、イタリア ・皮下ドラッグデリバリーデバイスのアジア市場規模2016年-2026年：中国、日本、韓国、インド、東南アジア、オーストラリア ・皮下ドラッグデリバリーデバイスの南米市場規模2016年-2026年：ブラジル、アルゼンチン ・皮下ドラッグデリバリーデバイスの中東・アフリカ市場規模2016年-2026年：サウジアラビア、トルコ、エジプト、南アフリカ ・販売チャネル、流通業者・代理店、顧客リスト ・調査の結果・結論 |
The Subcutaneous Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches, area marketplace expanding, and technological innovations.
According to our latest research, the global Subcutaneous Drug Delivery Devices size is estimated to be xx million in 2020 from USD xx million in 2019, with a change of XX% between 2019 and 2020. The global Subcutaneous Drug Delivery Devices market size is expected to grow at a CAGR of xx% for the next five years.
Market segmentation
Subcutaneous Drug Delivery Devices market is split by Type and by Application. For the period 2016-2026, the growth among segments provide accurate calculations and forecasts for sales by Type and by Application in terms of volume and value. This analysis can help you expand your business by targeting qualified niche markets.
Market segment by Type, covers
Prefilled Injectable
Filled Injectable
Market segment by Application can be divided into
Hospitals
Clinics
Others
The key market players for global Subcutaneous Drug Delivery Devices market are listed below:
BD
Insulet Corporation
Enable Injections
West Pharmaceutical Services, Inc
Ypsomed AG
Elcam Medical
Amgen
Wilhelm Haselmeier
Market segment by Region, regional analysis covers
North America (United States, Canada and Mexico)
Europe (Germany, France, United Kingdom, Russia, Italy, and Rest of Europe)
Asia-Pacific (China, Japan, Korea, India, Southeast Asia, and Australia)
South America (Brazil, Argentina, Colombia, and Rest of South America)
Middle East & Africa (Saudi Arabia, UAE, Egypt, South Africa, and Rest of Middle East & Africa)
1 Market Overview
1.1 Subcutaneous Drug Delivery Devices Introduction
1.2 Market Analysis by Type
1.2.1 Overview: Global Subcutaneous Drug Delivery Devices Revenue by Type: 2019 Versus 2021 Versus 2026
1.2.2 Prefilled Injectable
1.2.3 Filled Injectable
1.3 Market Analysis by Application
1.3.1 Overview: Global Subcutaneous Drug Delivery Devices Revenue by Application: 2019 Versus 2021 Versus 2026
1.3.2 Hospitals
1.3.3 Clinics
1.3.4 Others
1.4 Global Subcutaneous Drug Delivery Devices Market Size & Forecast
1.4.1 Global Subcutaneous Drug Delivery Devices Sales in Value (2016-2026))
1.4.2 Global Subcutaneous Drug Delivery Devices Sales in Volume (2016-2026)
1.4.3 Global Subcutaneous Drug Delivery Devices Price by Type (2016-2026) & (USD/Unit)
1.5 Global Subcutaneous Drug Delivery Devices Production Capacity Analysis
1.5.1 Global Subcutaneous Drug Delivery Devices Total Production Capacity (2016-2026)
1.5.2 Global Subcutaneous Drug Delivery Devices Production Capacity by Geographic Region
1.6 Market Drivers, Restraints and Trends
1.6.1 Subcutaneous Drug Delivery Devices Market Drivers
1.6.2 Subcutaneous Drug Delivery Devices Market Restraints
1.6.3 Subcutaneous Drug Delivery Devices Trends Analysis
2 Manufacturers Profiles
2.1 BD
2.1.1 BD Details
2.1.2 BD Major Business
2.1.3 BD Subcutaneous Drug Delivery Devices Product and Services
2.1.4 BD Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.2 Insulet Corporation
2.2.1 Insulet Corporation Details
2.2.2 Insulet Corporation Major Business
2.2.3 Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services
2.2.4 Insulet Corporation Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.3 Enable Injections
2.3.1 Enable Injections Details
2.3.2 Enable Injections Major Business
2.3.3 Enable Injections Subcutaneous Drug Delivery Devices Product and Services
2.3.4 Enable Injections Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.4 West Pharmaceutical Services, Inc
2.4.1 West Pharmaceutical Services, Inc Details
2.4.2 West Pharmaceutical Services, Inc Major Business
2.4.3 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services
2.4.4 West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.5 Ypsomed AG
2.5.1 Ypsomed AG Details
2.5.2 Ypsomed AG Major Business
2.5.3 Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services
2.5.4 Ypsomed AG Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.6 Elcam Medical
2.6.1 Elcam Medical Details
2.6.2 Elcam Medical Major Business
2.6.3 Elcam Medical Subcutaneous Drug Delivery Devices Product and Services
2.6.4 Elcam Medical Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.7 Amgen
2.7.1 Amgen Details
2.7.2 Amgen Major Business
2.7.3 Amgen Subcutaneous Drug Delivery Devices Product and Services
2.7.4 Amgen Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
2.8 Wilhelm Haselmeier
2.8.1 Wilhelm Haselmeier Details
2.8.2 Wilhelm Haselmeier Major Business
2.8.3 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services
2.8.4 Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales, Price, Revenue, Gross Margin and Market Share (2019-2021e)
3 Subcutaneous Drug Delivery Devices Sales by Manufacturer
3.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Manufacturer (2019-2021e)
3.2 Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2019-2021e)
3.3 Key Manufacturer Market Position in Subcutaneous Drug Delivery Devices
3.4 Market Concentration Rate
3.4.1 Top 3 Subcutaneous Drug Delivery Devices Manufacturer Market Share
3.4.2 Top 6 Subcutaneous Drug Delivery Devices Manufacturer Market Share
3.5 Global Subcutaneous Drug Delivery Devices Production Capacity by Company
3.6 Manufacturer by Geography: Head Office and Subcutaneous Drug Delivery Devices Production Site
3.7 New Entrant and Capacity Expansion Plans
3.8 Mergers & Acquisitions
4 Market Analysis by Region
4.1 Global Subcutaneous Drug Delivery Devices Market Size by Region
4.1.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Region (2016-2026)
4.1.2 Global Subcutaneous Drug Delivery Devices Revenue by Region (2016-2026)
4.2 North America Subcutaneous Drug Delivery Devices Revenue (2016-2026)
4.3 Europe Subcutaneous Drug Delivery Devices Revenue (2016-2026)
4.4 Asia-Pacific Subcutaneous Drug Delivery Devices Revenue (2016-2026)
4.5 South America Subcutaneous Drug Delivery Devices Revenue (2016-2026)
4.6 Middle East and Africa Subcutaneous Drug Delivery Devices Revenue (2016-2026)
5 Market Segment by Type
5.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Type (2016-2026)
5.2 Global Subcutaneous Drug Delivery Devices Revenue by Type (2016-2026)
5.3 Global Subcutaneous Drug Delivery Devices Price by Type (2016-2026)
6 Market Segment by Application
6.1 Global Subcutaneous Drug Delivery Devices Sales in Volume by Application (2016-2026)
6.2 Global Subcutaneous Drug Delivery Devices Revenue by Application (2016-2026)
6.3 Global Subcutaneous Drug Delivery Devices Price by Application (2016-2026)
7 North America by Country, by Type, and by Application
7.1 North America Subcutaneous Drug Delivery Devices Sales by Type (2016-2026)
7.2 North America Subcutaneous Drug Delivery Devices Sales by Application (2016-2026)
7.3 North America Subcutaneous Drug Delivery Devices Market Size by Country
7.3.1 North America Subcutaneous Drug Delivery Devices Sales in Volume by Country (2016-2026)
7.3.2 North America Subcutaneous Drug Delivery Devices Revenue by Country (2016-2026)
7.3.3 United States Market Size and Forecast (2016-2026)
7.3.4 Canada Market Size and Forecast (2016-2026)
7.3.5 Mexico Market Size and Forecast (2016-2026)
8 Europe by Country, by Type, and by Application
8.1 Europe Subcutaneous Drug Delivery Devices Sales by Type (2016-2026)
8.2 Europe Subcutaneous Drug Delivery Devices Sales by Application (2016-2026)
8.3 Europe Subcutaneous Drug Delivery Devices Market Size by Country
8.3.1 Europe Subcutaneous Drug Delivery Devices Sales in Volume by Country (2016-2026)
8.3.2 Europe Subcutaneous Drug Delivery Devices Revenue by Country (2016-2026)
8.3.3 Germany Market Size and Forecast (2016-2026)
8.3.4 France Market Size and Forecast (2016-2026)
8.3.5 United Kingdom Market Size and Forecast (2016-2026)
8.3.6 Russia Market Size and Forecast (2016-2026)
8.3.7 Italy Market Size and Forecast (2016-2026)
9 Asia-Pacific by Country, by Type, and by Application
9.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Type (2016-2026)
9.2 Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Application (2016-2026)
9.3 Asia-Pacific Subcutaneous Drug Delivery Devices Market Size by Region
9.3.1 Asia-Pacific Subcutaneous Drug Delivery Devices Sales in Volume by Region (2016-2026)
9.3.2 Asia-Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2016-2026)
9.3.3 China Market Size and Forecast (2016-2026)
9.3.4 Japan Market Size and Forecast (2016-2026)
9.3.5 Korea Market Size and Forecast (2016-2026)
9.3.6 India Market Size and Forecast (2016-2026)
9.3.7 Southeast Asia Market Size and Forecast (2016-2026)
9.3.8 Australia Market Size and Forecast (2016-2026)
10 South America by Country, by Type, and by Application
10.1 South America Subcutaneous Drug Delivery Devices Sales by Type (2016-2026)
10.2 South America Subcutaneous Drug Delivery Devices Sales by Application (2016-2026)
10.3 South America Subcutaneous Drug Delivery Devices Market Size by Country
10.3.1 South America Subcutaneous Drug Delivery Devices Sales in Volume by Country (2016-2026)
10.3.2 South America Subcutaneous Drug Delivery Devices Revenue by Country (2016-2026)
10.3.3 Brazil Market Size and Forecast (2016-2026)
10.3.4 Argentina Market Size and Forecast (2016-2026)
11 Middle East & Africa by Country, by Type, and by Application
11.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Type (2016-2026)
11.2 Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Application (2016-2026)
11.3 Middle East & Africa Subcutaneous Drug Delivery Devices Market Size by Country
11.3.1 Middle East & Africa Subcutaneous Drug Delivery Devices Sales in Volume by Country (2016-2026)
11.3.2 Middle East & Africa Subcutaneous Drug Delivery Devices Revenue by Country (2016-2026)
11.3.3 Turkey Market Size and Forecast (2016-2026)
11.3.4 Egypt Market Size and Forecast (2016-2026)
11.3.5 Saudi Arabia Market Size and Forecast (2016-2026)
11.3.6 South Africa Market Size and Forecast (2016-2026)
12 Sales Channel, Distributors, Traders and Dealers
12.1 Sales Channel
12.1.1 Direct Marketing
12.1.2 Indirect Marketing
12.2 Subcutaneous Drug Delivery Devices Typical Distributors
12.3 Subcutaneous Drug Delivery Devices Typical Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Methodology
14.2 Research Process and Data Source
14.3 Disclaimer
Table 1. Global Subcutaneous Drug Delivery Devices Revenue by Type, (USD Million), 2021-2026
Table 2. Global Subcutaneous Drug Delivery Devices Revenue by Application, (USD Million), 2021-2026
Table 3. BD Basic Information, Manufacturing Base and Competitors
Table 4. BD Major Business
Table 5. BD Subcutaneous Drug Delivery Devices Product and Services
Table 6. BD Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 7. Insulet Corporation Basic Information, Manufacturing Base and Competitors
Table 8. Insulet Corporation Major Business
Table 9. Insulet Corporation Subcutaneous Drug Delivery Devices Product and Services
Table 10. Insulet Corporation Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 11. Enable Injections Basic Information, Manufacturing Base and Competitors
Table 12. Enable Injections Major Business
Table 13. Enable Injections Subcutaneous Drug Delivery Devices Product and Services
Table 14. Enable Injections Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 15. West Pharmaceutical Services, Inc Basic Information, Manufacturing Base and Competitors
Table 16. West Pharmaceutical Services, Inc Major Business
Table 17. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Product and Services
Table 18. West Pharmaceutical Services, Inc Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 19. Ypsomed AG Basic Information, Manufacturing Base and Competitors
Table 20. Ypsomed AG Major Business
Table 21. Ypsomed AG Subcutaneous Drug Delivery Devices Product and Services
Table 22. Ypsomed AG Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 23. Elcam Medical Basic Information, Manufacturing Base and Competitors
Table 24. Elcam Medical Major Business
Table 25. Elcam Medical Subcutaneous Drug Delivery Devices Product and Services
Table 26. Elcam Medical Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 27. Amgen Basic Information, Manufacturing Base and Competitors
Table 28. Amgen Major Business
Table 29. Amgen Subcutaneous Drug Delivery Devices Product and Services
Table 30. Amgen Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 31. Wilhelm Haselmeier Basic Information, Manufacturing Base and Competitors
Table 32. Wilhelm Haselmeier Major Business
Table 33. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Product and Services
Table 34. Wilhelm Haselmeier Subcutaneous Drug Delivery Devices Sales (K Units), Price (USD/Unit), Revenue (USD Million), Gross Margin and Market Share (2019-2021e)
Table 35. Global Subcutaneous Drug Delivery Devices Sales by Manufacturer (2019-2021e) & (K Units)
Table 36. Global Subcutaneous Drug Delivery Devices Revenue by Manufacturer (2019-2021e) & (USD Million)
Table 37. Market Position of Manufacturers in Subcutaneous Drug Delivery Devices, (Tier 1, Tier 2, and Tier 3), Based on Revenue in 2020
Table 38. Global Subcutaneous Drug Delivery Devices Production Capacity by Company, (K Units): 2020 VS 2021
Table 39. Head Office and Subcutaneous Drug Delivery Devices Production Site of Key Manufacturer
Table 40. Global Subcutaneous Drug Delivery Devices Sales by Region (2016-2021e) & (K Units)
Table 41. Global Subcutaneous Drug Delivery Devices Sales by Region (2021-2026) & (K Units)
Table 42. Global Subcutaneous Drug Delivery Devices Revenue by Region (2016-2021e) & (USD Million)
Table 43. Global Subcutaneous Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)
Table 44. Global Subcutaneous Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 45. Global Subcutaneous Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 46. Global Subcutaneous Drug Delivery Devices Revenue by Type (2016-2021e) & (USD Million)
Table 47. Global Subcutaneous Drug Delivery Devices Revenue by Type (2021-2026) & (USD Million)
Table 48. Global Subcutaneous Drug Delivery Devices Price by Type (2016-2021e) & (USD/Unit)
Table 49. Global Subcutaneous Drug Delivery Devices Price by Type (2021-2026) & (USD/Unit)
Table 50. Global Subcutaneous Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 51. Global Subcutaneous Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 52. Global Subcutaneous Drug Delivery Devices Revenue by Application (2016-2021e) & (USD Million)
Table 53. Global Subcutaneous Drug Delivery Devices Revenue by Application (2021-2026) & (USD Million)
Table 54. Global Subcutaneous Drug Delivery Devices Price by Application (2016-2021e) & (USD/Unit)
Table 55. Global Subcutaneous Drug Delivery Devices Price by Application (2021-2026) & (USD/Unit)
Table 56. North America Subcutaneous Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 57. North America Subcutaneous Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 58. North America Subcutaneous Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 59. North America Subcutaneous Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 60. North America Subcutaneous Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 61. North America Subcutaneous Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 62. North America Subcutaneous Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 63. North America Subcutaneous Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 64. Europe Subcutaneous Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 65. Europe Subcutaneous Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 66. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 67. Europe Subcutaneous Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 68. Europe Subcutaneous Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 69. Europe Subcutaneous Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 70. Europe Subcutaneous Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 71. Europe Subcutaneous Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 72. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Region (2016-2021e) & (K Units)
Table 73. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Region (2021-2026) & (K Units)
Table 74. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2016-2021e) & (USD Million)
Table 75. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue by Region (2021-2026) & (USD Million)
Table 76. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 77. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 78. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 79. Asia-Pacific Subcutaneous Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 80. South America Subcutaneous Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 81. South America Subcutaneous Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 82. South America Subcutaneous Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 83. South America Subcutaneous Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 84. South America Subcutaneous Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 85. South America Subcutaneous Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 86. South America Subcutaneous Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 87. South America Subcutaneous Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 88. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Country (2016-2021e) & (K Units)
Table 89. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Country (2021-2026) & (K Units)
Table 90. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue by Country (2016-2021e) & (USD Million)
Table 91. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue by Country (2021-2026) & (USD Million)
Table 92. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Type (2016-2021e) & (K Units)
Table 93. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Type (2021-2026) & (K Units)
Table 94. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Application (2016-2021e) & (K Units)
Table 95. Middle East & Africa Subcutaneous Drug Delivery Devices Sales by Application (2021-2026) & (K Units)
Table 96. Direct Channel Pros & Cons
Table 97. Indirect Channel Pros & Cons
Table 98. Subcutaneous Drug Delivery Devices Typical Distributors
Table 99. Subcutaneous Drug Delivery Devices Typical Customers
List of Figures
Figure 1. Subcutaneous Drug Delivery Devices Picture
Figure 2. Global Subcutaneous Drug Delivery Devices Sales Market Share by Type in 2020
Figure 3. Prefilled Injectable
Figure 4. Filled Injectable
Figure 5. Global Subcutaneous Drug Delivery Devices Sales Market Share by Application in 2020
Figure 6. Hospitals
Figure 7. Clinics
Figure 8. Others
Figure 9. Global Subcutaneous Drug Delivery Devices Market Size, (USD Million) & (K Units): 2020 VS 2021 VS 2026
Figure 10. Global Subcutaneous Drug Delivery Devices Market Size and Forecast (2016-2026) & (USD Million)
Figure 11. United States Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 12. Canada Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 13. Mexico Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 14. Germany Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 15. France Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 16. United Kingdom Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 17. Russia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 18. Italy Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 19. China Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 20. Japan Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 21. Korea Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 22. India Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 23. Southeast Asia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 24. Australia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 25. Brazil Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 26. Egypt Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 27. Saudi Arabia Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 28. South Africa Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 29. Turkey Subcutaneous Drug Delivery Devices Revenue and Growth Rate (2016-2026) & (USD Million)
Figure 30. Global Subcutaneous Drug Delivery Devices Sales (2016-2026) & (K Units)
Figure 31. Global Subcutaneous Drug Delivery Devices Production Capacity (2016-2026) & (K Units)
Figure 32. Global Subcutaneous Drug Delivery Devices Production Capacity by Geographic Region: 2020 VS 2021
Figure 33. Subcutaneous Drug Delivery Devices Market Drivers
Figure 34. Subcutaneous Drug Delivery Devices Market Restraints
Figure 35. Subcutaneous Drug Delivery Devices Market Trends
Figure 36. Global Subcutaneous Drug Delivery Devices Sales Market Share by Manufacturer in 2020
Figure 37. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Manufacturer in 2020
Figure 38. Subcutaneous Drug Delivery Devices Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
Figure 39. Top 3 Subcutaneous Drug Delivery Devices Manufacturer (Revenue) Market Share in 2020
Figure 40. Top 6 Subcutaneous Drug Delivery Devices Manufacturer (Revenue) Market Share in 2020
Figure 41. Global Subcutaneous Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 42. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2016-2026)
Figure 43. North America Subcutaneous Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 44. Europe Subcutaneous Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 45. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 46. South America Subcutaneous Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 47. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue (2016-2026) & (USD Million)
Figure 48. Global Subcutaneous Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 49. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Type (2016-2026)
Figure 50. Global Subcutaneous Drug Delivery Devices Price by Type (2016-2026) & (USD/Unit)
Figure 51. Global Subcutaneous Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 52. Global Subcutaneous Drug Delivery Devices Revenue Market Share by Application (2016-2026)
Figure 53. Global Subcutaneous Drug Delivery Devices Price by Application (2016-2026) & (USD/Unit)
Figure 54. North America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 55. North America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 56. North America Subcutaneous Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 57. North America Subcutaneous Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 58. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 59. Europe Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 60. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 61. Europe Subcutaneous Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 62. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 63. Asia-Pacific Subcutaneous Drug Delivery Devices Revenue Market Share by Region (2016-2026)
Figure 64. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Region (2016-2026)
Figure 65. Asia-Pacific Subcutaneous Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 66. South America Subcutaneous Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 67. South America Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 68. South America Subcutaneous Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 69. South America Subcutaneous Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 70. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Market Share by Country (2016-2026)
Figure 71. Middle East & Africa Subcutaneous Drug Delivery Devices Revenue Market Share by Country (2016-2026)
Figure 72. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Market Share by Type (2016-2026)
Figure 73. Middle East & Africa Subcutaneous Drug Delivery Devices Sales Market Share by Application (2016-2026)
Figure 74. Sales Channel: Direct Channel vs Indirect Channel
Figure 75. Methodology
Figure 76. Research Process and Data Source
世界のコネクテッドドラッグデリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The Connected Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade…- 薬物および遺伝子送達装置の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Drug And Gene Delivery Devices provides a new treatment method, become the main treatment of the global market. Scope of the Report: This report focuses on the Drug And Gene Delivery Devices in global market, especially in North America, Europe and Asia-Pacific, South America, Middle East and Africa…
- 世界の経粘膜ドラッグデリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The Transmucosal Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, tr…
- 世界のCOPD用ドラッグデリバリーデバイス市場 2021：企業別、地域別、種類・用途別 The COPD Drug Delivery Devices market report provides a detailed analysis of global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players, value chain optimization, trade regu…
- 埋め込み型薬物送達装置の世界市場予測 2023年：メーカー別、地域別、種類・用途別 Implantable drug delivery devices are used to administer drugs and fluids without the repeated insertion of needles. This product circumvents the need for patients to be hospitalized for intravenous infusion. Scope of the Report: This report focuses on the Implantable Drug Delivery Devices in global…